New AI-driven platform enhances lung cancer tissue analysis

FHS
August 23, 2024
10:48 pm

A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence.

Study reveals disparities in cleft lip surgery for non-White children

Children of non-White racial/ethnic backgrounds experience significant disparities in access to and outcomes of surgery to repair cleft lip, reports a study in the November

November 1, 2024

Psychedelics Reform Update From Several States In The Union

Since our previous roundup, whether inside state legislatures or out on the streets, there’s been some consistent movement of proposals concerning psychedelics. As of Sept. 28: Massachusetts:

October 2, 2023

Menarini signs agreement for Astellas’ rheumatoid arthritis therapy

Smyraf is intended for the treatment of rheumatoid arthritis. Credit: BlurryMe/Shutterstock.com. Menarini Asia-Pacific has entered a long-term exclusive agreement to license Astellas Pharma’s Smyraf to

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.